Panbela Therapeutics, Inc. (PBLA)
USD 0.35
(10.54%)
USD 0.35
(10.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 25.64 Million | 35.73 Million | 10.01 Million | 5.75 Million | 4.32 Million | 3.89 Million |
| Gross Profit | -25.64 Million | -35.73 Million | -10.01 Million | -5.75 Million | -4.32 Million | -3.89 Million |
| Operating Expenses | 25.64 Million | 34.09 Million | 10.01 Million | 5.75 Million | 4.32 Million | 3.83 Million |
| Selling, General and Administrative Expenses | 5.03 Million | 6.04 Million | 4.58 Million | 3.24 Million | 1.97 Million | 2.1 Million |
| Research and Development Expenses | 20.61 Million | 28.04 Million | 5.42 Million | 2.5 Million | 2.34 Million | 1.78 Million |
| Other Expenses | - | -682 Thousand | -602 Thousand | 605 Thousand | -99 Thousand | -508 Thousand |
| Cost and Expenses | 51.29 Million | 34.09 Million | 10.01 Million | 5.75 Million | 4.32 Million | 3.83 Million |
| Operating Income | -51.29 Million | -34.09 Million | -10.01 Million | -5.75 Million | -4.32 Million | -3.89 Million |
| Interest Expense | -317 Thousand | 288 Thousand | 11 Thousand | 17 Thousand | 2.19 Million | 1.81 Million |
| Income Tax Expense | -186 Thousand | -116 Thousand | -488 Thousand | -295 Thousand | -415 Thousand | -254 Thousand |
| Earnings before Tax | -25.44 Million | -35.04 Million | -10.62 Million | -5.06 Million | -6.61 Million | -6.15 Million |
| Net Income | -25.26 Million | -34.93 Million | -10.13 Million | -4.76 Million | -6.2 Million | -5.9 Million |
| Earnings Per Share Basic | -232.42 Thousand | -40.74 Thousand | -20.77 Thousand | -14.79 Thousand | -26.1 Thousand | -1519.95 |
| Earnings Per Share Diluted | -232.42 Thousand | -40.74 Thousand | -20.77 Thousand | -14.79 Thousand | -26.1 Thousand | -1519.95 |
| Weighted Average Shares Outstanding | 108.69 | 857.28 | 487.88 | 322.20 | 237.51 | 3885.00 |
| Weighted Average Shares Outstanding (Diluted) | 108.69 | 857.28 | 487.88 | 322.20 | 237.51 | 3885.00 |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -51.29 Million | -34.76 Million | -10.61 Million | -5.14 Million | -4.42 Million | -1.76 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 8.1 Million | 6.72 Million | 25.64 Million | 7.04 Million | 7.84 Million | 5.87 Million |
| Gross Profit | -8.1 Million | -6.72 Million | -25.64 Million | -7.04 Million | -7.84 Million | -5.87 Million |
| Operating Expenses | 8.1 Million | 6.72 Million | 25.64 Million | 7.04 Million | 7.84 Million | 5.87 Million |
| Selling, General and Administrative Expenses | 1.1 Million | 1.2 Million | - | 931 Thousand | 1.1 Million | 1.64 Million |
| Research and Development Expenses | 6.99 Million | 5.52 Million | - | 6.11 Million | 6.73 Million | 4.23 Million |
| Other Expenses | 248 Thousand | -469 Thousand | - | 614 Thousand | -382 Thousand | -82 Thousand |
| Cost and Expenses | 8.1 Million | 6.72 Million | 51.29 Million | 7.04 Million | 15.69 Million | 5.87 Million |
| Operating Income | -8.1 Million | -6.72 Million | -51.29 Million | -7.04 Million | -15.69 Million | -5.87 Million |
| Interest Expense | 59 Thousand | 63 Thousand | -317 Thousand | 72 Thousand | -71 Thousand | 70 Thousand |
| Income Tax Expense | 59 Thousand | -138 Thousand | -186 Thousand | -19 Thousand | -19 Thousand | -147 Thousand |
| Earnings before Tax | -7.13 Million | -7.25 Million | -25.44 Million | -6.49 Million | -7.85 Million | -5.98 Million |
| Net Income | -7.13 Million | -7.12 Million | -25.26 Million | -6.47 Million | -7.83 Million | -5.83 Million |
| Earnings Per Share Basic | -1.47 | -2.28 | - | -0.03 | -53.74 | -159.09 |
| Earnings Per Share Diluted | -1.47 | -2.28 | - | -0.03 | -53.74 | -159.09 |
| Weighted Average Shares Outstanding | 4.85 Million | 3.12 Million | 108.69 | 237.23 Million | 145.73 Thousand | 36.66 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.85 Million | 3.12 Million | 108.69 | 237.23 Million | 145.73 Thousand | 36.66 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -7.85 Million | -7.19 Million | - | -6.42 Million | -15.69 Million | -5.91 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
1293
QINTER
VIMGF
LKHLY
RIV
CVCB3